This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Unaudited Sep 2026 standalone quarter: revenue up 113% year on year; net profit Rs 92.52 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue was Rs 1,280.74 lakh versus Rs 601.43 lakh a year ago, up 113%; net profit was Rs 92.52 lakh versus a loss of Rs 56.79 lakh. Earnings before interest, tax, depreciation and amortisation were Rs 150.1 lakh, an 11.7% margin versus negative 5.4%. Standalone half-year net profit was Rs 191.01 lakh; cash from operations was positive Rs 48.35 lakh. Related-party transactions were disclosed.
Positive: revenue more than doubled and profit after tax turned positive. High receivables and inventory mean working capital needs attention.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹12.81 Cr | ₹6.01 Cr | +112.9% |
| Operating profit | ₹1.06 Cr | −₹0.75 Cr | turned positive |
| Profit after tax | ₹0.93 Cr | −₹0.57 Cr | turned positive |
| EBITDA margin | 11.7% | -5.4% | +17.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.